Annexin II overexpression correlates with stromal tenascin‐C overexpression

Overexpression of annexin II, a calcium‐dependent phospholipid‐binding protein, has been reported in various carcinomas. One of its ligands is tenascin‐C, an extracellular matrix glycoprotein with predominantly antiadhesive qualities that also has been reported to be a prognostic marker for several carcinomas. In the current study, the authors investigated the correlation between the overexpression of annexin II and tenascin‐C in colorectal carcinoma.

[1]  M. Hollingsworth,et al.  Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. , 1993, Carcinogenesis.

[2]  M. Pinkoski,et al.  Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. , 1992, British Journal of Cancer.

[3]  M. Jost,et al.  Mapping of three unique Ca(2+)-binding sites in human annexin II. , 1992, European journal of biochemistry.

[4]  M. McLaughlin,et al.  Annexin II and bleeding in acute promyelocytic leukemia. , 1999, The New England journal of medicine.

[5]  M. Geisow,et al.  The annexin family of calcium-binding proteins. Review article. , 1989, Cell calcium.

[6]  C. Kahn,et al.  Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver. , 1988, The Journal of biological chemistry.

[7]  A. Puisieux,et al.  Annexin II upregulates cellular levels of p 11 protein by a post-translational mechanism , 1996 .

[8]  Norifumi Ueda,et al.  Modulation of S‐100 genes response to growth conditions in human epithelial tumor cells , 1997, Pathology international.

[9]  T. Sakakura,et al.  Co‐expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast , 1997, The Journal of pathology.

[10]  K. Koretz,et al.  Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. , 1993, Differentiation; research in biological diversity.

[11]  J. Paavonen,et al.  Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. , 1992, American Journal of Pathology.

[12]  D.,et al.  Regression Models and Life-Tables , 2022 .

[13]  S. Cohen,et al.  Epidermal growth factor stimulates the phosphorylation of the calcium-dependent 35,000-dalton substrate in intact A-431 cells. , 1985, The Journal of biological chemistry.

[14]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.

[15]  K. Schmid,et al.  Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study , 1998, Histochemistry and Cell Biology.

[16]  T. Toivonen,et al.  Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis , 1996, International journal of cancer.

[17]  H. Erickson,et al.  Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. , 1996, Molecular biology of the cell.

[18]  J. Wands,et al.  Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. , 1990, Molecular and cellular biology.

[19]  J. Glenney,et al.  Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Bastian Annexins in cancer and autoimmune diseases , 1997, Cellular and Molecular Life Sciences CMLS.

[21]  J. J. Steinberg,et al.  Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer , 1997, Journal of surgical oncology.

[22]  H. Kawakatsu,et al.  Specific expression of tenascin in human colonic neoplasms. , 1993, British Journal of Cancer.

[23]  S. Kain,et al.  Human multiple tissue western blots: a new immunological tool for the analysis of tissue-specific protein expression. , 1994, BioTechniques.

[24]  T. Tsuruo,et al.  Expression of platelet‐derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma , 2000, Cancer.

[25]  M. Kusakabe,et al.  Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. , 1988, Developmental biology.

[26]  L. Alberghina,et al.  Characterization of the tyrosine phosphorylation of calpactin I (annexin II) induced by platelet-derived growth factor. , 1991, The Biochemical journal.

[27]  P. Möller,et al.  Tenascin-C tissue concentration in inflammatory and neoplastic diseases of the colon mucosa. , 1997, Anticancer research.

[28]  B. Rothhut Participation of annexins in protein phosphorylation , 1997, Cellular and Molecular Life Sciences CMLS.

[29]  Y. Kawarada,et al.  Tenascin is a stromal marker for epithelial malignancy in the mammary gland. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Påhlman,et al.  Stromal tenascin distribution as a prognostic marker in colorectal cancer. , 1997, British Journal of Cancer.

[31]  A. Verstraeten,et al.  Tenascin expression in basal cell carcinoma , 1992, The British journal of dermatology.

[32]  E. Mackie Molecules in focus: tenascin-C. , 1997, The international journal of biochemistry & cell biology.

[33]  A. Puisieux,et al.  Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms. , 1996, The Biochemical journal.

[34]  T. Sakakura,et al.  Combined Analysis of Expression of c‐evbB‐2, Ki‐67 Antigen, and Tenascin Provides a Better Prognostic Indicator of Carcinoma of the Papilla of Vater , 1996, Pancreas.

[35]  F. Real,et al.  The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro , 1998, Oncogene.

[36]  S. Shintani,et al.  Extracellular matrices expression in invasion area of adenoid cystic carcinoma of salivary glands. , 1997, Cancer letters.

[37]  A. Harris,et al.  Combined role of tumor angiogenesis, bcl‐2, and p53 expression in the prognosis of patients with colorectal carcinoma , 1999, Cancer.

[38]  I. Yada,et al.  Expression and degeneration of tenascin-C in human lung cancers. , 1998, British Journal of Cancer.

[39]  J. Vishwanatha,et al.  Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. , 1992, Cancer research.

[40]  I. Virtanen,et al.  Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[41]  J. Browning,et al.  Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates. , 1986, The Journal of biological chemistry.

[42]  K. Titani,et al.  Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. , 1991, Cancer research.

[43]  M. Israel,et al.  Annexin II marks astrocytic brain tumors of high histologic grade. , 1994, Oncology research.

[44]  Z. Werb,et al.  The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. , 1994, Molecular biology of the cell.

[45]  H. Hidaka,et al.  Ca2+ signaling and intracellular Ca2+ binding proteins. , 1996, Journal of biochemistry.

[46]  P. Carreira,et al.  Survival of patients with colorectal carcinoma , 1999, Cancer.

[47]  T. Sakakura,et al.  Analysis of tenascin mRNA expression in the murine mammary gland from embryogenesis to carcinogenesis: an in situ hybridization study. , 1997, The International journal of developmental biology.

[48]  H. Erickson,et al.  Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C , 1994, The Journal of cell biology.

[49]  J. Vishwanatha,et al.  Altered expression of annexin II in human B-cell lymphoma cell lines. , 1996, Biochimica et biophysica acta.

[50]  C. Creutz The annexins and exocytosis. , 1992, Science.